Your browser doesn't support javascript.
loading
Compact zinc finger architecture utilizing toxin-derived cytidine deaminases for highly efficient base editing in human cells.
Fauser, Friedrich; Kadam, Bhakti N; Arangundy-Franklin, Sebastian; Davis, Jessica E; Vaidya, Vishvesha; Schmidt, Nicola J; Lew, Garrett; Xia, Danny F; Mureli, Rakshaa; Ng, Colman; Zhou, Yuanyue; Scarlott, Nicholas A; Eshleman, Jason; Bendaña, Yuri R; Shivak, David A; Reik, Andreas; Li, Patrick; Davis, Gregory D; Miller, Jeffrey C.
Afiliação
  • Fauser F; Sangamo Therapeutics, Inc., Brisbane, CA, USA.
  • Kadam BN; Sangamo Therapeutics, Inc., Brisbane, CA, USA.
  • Arangundy-Franklin S; Sangamo Therapeutics, Inc., Brisbane, CA, USA.
  • Davis JE; Sangamo Therapeutics, Inc., Brisbane, CA, USA.
  • Vaidya V; Sangamo Therapeutics, Inc., Brisbane, CA, USA.
  • Schmidt NJ; Sangamo Therapeutics, Inc., Brisbane, CA, USA.
  • Lew G; Sangamo Therapeutics, Inc., Brisbane, CA, USA.
  • Xia DF; Sangamo Therapeutics, Inc., Brisbane, CA, USA.
  • Mureli R; Sangamo Therapeutics, Inc., Brisbane, CA, USA.
  • Ng C; Sangamo Therapeutics, Inc., Brisbane, CA, USA.
  • Zhou Y; Sangamo Therapeutics, Inc., Brisbane, CA, USA.
  • Scarlott NA; Sangamo Therapeutics, Inc., Brisbane, CA, USA.
  • Eshleman J; Sangamo Therapeutics, Inc., Brisbane, CA, USA.
  • Bendaña YR; Sangamo Therapeutics, Inc., Brisbane, CA, USA.
  • Shivak DA; Sangamo Therapeutics, Inc., Brisbane, CA, USA.
  • Reik A; Sangamo Therapeutics, Inc., Brisbane, CA, USA.
  • Li P; Sangamo Therapeutics, Inc., Brisbane, CA, USA.
  • Davis GD; Sangamo Therapeutics, Inc., Brisbane, CA, USA.
  • Miller JC; Sangamo Therapeutics, Inc., Brisbane, CA, USA. jmiller@sangamo.com.
Nat Commun ; 15(1): 1181, 2024 Feb 15.
Article em En | MEDLINE | ID: mdl-38360922
ABSTRACT
Nucleobase editors represent an emerging technology that enables precise single-base edits to the genomes of eukaryotic cells. Most nucleobase editors use deaminase domains that act upon single-stranded DNA and require RNA-guided proteins such as Cas9 to unwind the DNA prior to editing. However, the most recent class of base editors utilizes a deaminase domain, DddAtox, that can act upon double-stranded DNA. Here, we target DddAtox fragments and a FokI-based nickase to the human CIITA gene by fusing these domains to arrays of engineered zinc fingers (ZFs). We also identify a broad variety of Toxin-Derived Deaminases (TDDs) orthologous to DddAtox that allow us to fine-tune properties such as targeting density and specificity. TDD-derived ZF base editors enable up to 73% base editing in T cells with good cell viability and favorable specificity.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Citidina Desaminase / Edição de Genes Limite: Humans Idioma: En Revista: Nat Commun Assunto da revista: BIOLOGIA / CIENCIA Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Citidina Desaminase / Edição de Genes Limite: Humans Idioma: En Revista: Nat Commun Assunto da revista: BIOLOGIA / CIENCIA Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Estados Unidos